Three-Statement Breakdown
REVENUE UP
Revenue rose 8.0% year over year to $48.0B, and carried a 10.2% net margin.
REVENUE
+8.0%
47,982
GROSS PROFIT
—
—
NET INCOME
-6.4%
4,873
EPS (DILUTED)
—
—
| Income statement | TTM 24-10 | TTM 25-01 | TTM 25-04 | TTM 25-07 | TTM 25-11 | TTM 26-02 | TTM 26-05 | vs prior TTM | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 51,716 | 48,039 | 45,567 | 44,433 | 45,683 | 46,786 | 47,392 | 47,982 | +1.2% | +8.0% | |
| Research & development | (2,290) | (2,283) | (2,267) | (2,256) | (2,311) | (2,339) | (2,373) | (2,384) | +0.5% | +5.7% | |
| SG&A | (4,840) | (4,746) | (4,678) | (4,617) | (4,662) | (4,662) | (4,674) | (4,677) | +0.1% | +1.3% | |
| Interest expense | (3,348) | (3,375) | (3,323) | (3,277) | (3,169) | (3,059) | (2,987) | (2,903) | -2.8% | -11.4% | |
| Income tax | (2,094) | (1,652) | (1,440) | (1,154) | (1,259) | (1,428) | (1,407) | (1,597) | +13.5% | +38.4% | |
| Net income | 7,100 | 6,218 | 5,652 | 5,207 | 5,027 | 4,814 | 4,783 | 4,873 | +1.9% | -6.4% | |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-08-27 ↗